Shipping to United States We Offer Worldwide Shipping
Login Wishlist

Wilfordine

$952

  • Brand : BIOFRON

  • Catalogue Number : BD-P0048

  • Specification : 95.0%(HPLC)

  • CAS number : 37239-51-3

  • Formula : C43H49NO19

  • Molecular Weight : 883.9

  • PUBCHEM ID : 442556

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BD-P0048

Analysis Method

Specification

95.0%(HPLC)

Storage

-20℃

Molecular Weight

883.9

Appearance

Powder

Botanical Source

This product is isolated and purified from the roots of Tripterygium wilfordii Hook. f.

Structure Type

Category

SMILES

CC(=O)OCC12C(C(C3C(C14C(C(C(C2OC(=O)C)OC(=O)C5=CC=CC=C5)OC(=O)C(CCC6=C(C=CC=N6)C(=O)OCC3(O4)C)(C)O)(C)O)OC(=O)C)OC(=O)C)OC(=O)C

Synonyms

IUPAC Name

Applications

Density

1.4±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

495.4±34.3 °C

Boiling Point

895.5±65.0 °C at 760 mmHg

Melting Point

InChl

InChl Key

XQDBHSNYTFRCNJ-OURLNJDISA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:37239-51-3) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

28422729

Abstract

Since low JAK2V617F allele burden (AB) has been detected also in healthy subjects, its clinical interpretation may be challenging in patients with chronic myeloproliferative neoplasms (MPNs). We tested 1087 subjects for JAK2V617F mutation on suspicion of hematological malignancy. Only 497 (45.7%) patients were positive. Here we present clinical and laboratory parameters of a cohort of 35/497 patients with an AB ≤ 3%.

Overall, 22/35 (62.9%) received a WHO-defined diagnosis of MPN and in 14/35 cases (40%) diagnosis was supported by bone marrow (BM) histology (‘’Histology-based’’ diagnosis). In patients that were unable or refused to perform BM evaluation, diagnosis relied on prospective clinical observation (12 cases, 34.3%) and molecular monitoring (6 cases, 17.1%) (‘’Clinical-based’’ or ‘’Molecular-based’’ diagnosis, respectively). In 11/35 (31.4%) patients, a low JAK2V617F AB was not conclusive of MPN. The probability to have a final hematological diagnosis (ET/PV/MF) was higher in patients with thrombocytosis than in patients with polyglobulia (73.7% vs 57.1%, respectively). The detection of AB ≥ 0.8% always corresponded to an overt MPN phenotype. The repetition of JAK2V617F evaluation over time timely detected the spontaneous expansion (11 cases) or reduction (4 cases) of JAK2V617F-positive clones and significantly oriented the diagnostic process.

Our study confirms that histology is relevant to discriminate small foci of clonal hematopoiesis with uncertain clinical significance from a full blown disease. Remarkably, our data suggest that a cut-off of AB ≥ 0.8% is very indicative for the presence of a MPN. Monitoring of the AB over time emerged as a convenient and non-invasive method to assess clonal hematopoiesis expansion.

KEYWORDS

JAK2, V617F mutation, allele burden, myeloproliferative neoplasms, MPN

Title

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study

Author

Margherita Perricone,#1 Nicola Polverelli,#1 Giovanni Martinelli,1 Lucia Catani,1 Emanuela Ottaviani,1 Elisa Zuffa,1 Eugenia Franchini,1 Arbana Dizdari,1 Dorian Forte,1 Elena Sabattini,2 Michele Cavo,1 Nicola Vianelli,1 and Francesca Palandri1

Publish date

2017 Jun 6

PMID

26594444

Abstract

In the title compound, C27H21NO4S, the dihedral angles between the carbazole ring system (r.m.s. deviation = 0.015 a) and the sulfur-bonded and directly linked benzene rings are 79.98 (11) and 53.51 (18)°, respectively. The benzene rings subtend a dihedral angle of 48.4 (2)°. The ethyl side chain of the ester group has an extended conformation [C—O—C—C = −172.3 (3)°]. In the crystal, inversion dimers linked by pairs of weak C—H⋯O hydrogen bonds generate R 2 2(22) loops. The dimers are linked by weak C—H⋯π and π-π [centroid-to-centroid distances ranging from 3.5042 (14) to 3.888 (2) a] inter­actions, thereby forming a three-dimensional supra­molecular network.

KEYWORDS

crystal structure, ester, phenyl­sulfon­yl, 9H-carbazole-3-carboxyl­ate, biological activity, indole derivatives, hydrogen bonding, C—H⋯π inter­actions, π-π inter­actions

Title

Crystal structure of ethyl 2-phenyl-9-phenyl­sulfonyl-9H-carbazole-3-carboxyl­ate

Author

M. Umadevi,a,b P. Raju,c R. Yamuna,d,* A. K. Mohanakrishnan,c and G. Chakkaravarthie,*

Publish date

2015 Oct 1

PMID

30673700

Abstract

Background
Many systematic reviews (SRs) have been published about the various treatments for distal radius fractures (DRF). The heterogeneity of SRs results may come from the misuse of SR methods, and literature overviews have demonstrated that SRs should be considered with caution as they may not always be synonymous with high-quality standards. Our objective is to evaluate the quality of published SRs on the treatment of DRF through these tools.

Methods
The methods utilized in this review were previously published in the PROSPERO database. We considered SRs of surgical and nonsurgical interventions for acute DRF in adults. A comprehensive search strategy was performed in the MEDLINE database (inception to May 2017) and we manually searched the grey literature for non-indexed research. Data were independently extracted by two authors. We assessed SR internal validity and reporting using AMSTAR (Assessing the Methodological Quality of Systematic Reviews and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes). Scores were calculated as the sum of reported items. We also extracted article characteristics and provided Spearman’s correlation measurements.

Results
Forty-one articles fulfilled the eligibility criteria. The mean score for PRISMA was 15.90 (CI 95%, 13.9-17.89) and AMSTAR was 6.48 (CI 95% 5.72-7.23). SRs that considered only RCTs had better AMSTAR [7.56 (2.1) vs. 5.62 (2.3); p = 0.014] and PRISMA scores [18.61 (5.22) vs. 13.93 (6.47), p = 0.027]. The presence of meta-analysis on the SRs altered PRISMA scores [19.17 (4.75) vs. 10.21 (4.51), p = 0.001] and AMSTAR scores [7.68 (1.9) vs. 4.39 (1.66), p = 0.001]. Journal impact factor or declaration of conflict of interest did not change PRISMA and AMSTAR scores. We found substantial inter observer agreement for PRISMA (0.82, 95% CI 0.62-0.94; p = 0.01) and AMSTAR (0.65, 95% CI 0.43-0.81; p = 0.01), and moderate correlation between PRISMA and AMSTAR scores (0.83, 95% CI 0.62-0.92; p = 0.01).

Conclusions
DRF RCT-only SRs have better PRISMA and AMSTAR scores. These tools have substantial inter-observer agreement and moderate inter-tool correlation. We exposed the current research panorama and pointed out some factors that can contribute to improvements on the topic.

Title

A systematic review of the quality of distal radius systematic reviews: Methodology and reporting assessment

Author

João Carlos Belloti, Conceptualization,#1,2 Aldo Okamura, Data curation, Formal analysis, Writing - review & editing,#1,2 Jordana Scheeren, Methodology,#1 Flavio Faloppa, Writing - review & editing,#1,2 and Vinicius Ynoe de Moraes, Conceptualization, Data curation, Methodology, Writing - original draft, Writing - review & editing#1,2,*

Publish date

2019;